Search Submit Your Manuscript

Become A Member

  1. Home
  2. December 2024
  3. 46. Impact of Metabolic Syndrome on the Progression of Coronary Artery Disease: An Observational Cohort Study
Article Image
Admin

46. Impact of Metabolic Syndrome on the Progression of Coronary Artery Disease: An Observational Cohort Study

Original Article

Metabolic Syndrome on the Progression of Coronary Artery Disease

Impact of Metabolic Syndrome on the Progression of Coronary Artery Disease: An Observational Cohort Study

Ghulam Hussain, Muhammad Farooq, Usman Sadiq, Gohar Ali, Muhammad Shahid Nawaz Khan and Muhammad Tahir

ABSTRACT

Objective:The objective of study was to evaluate the impact of MetS on the progression of CAD across diverse patient populations.

Study Design:An observational cohort study

Place and Duration of Study: This study was conducted at thedepartment of Medicine and Cardiology at Nishtar II Medical University and Hospital, Multan, from September 2023 to August 2024.

Methods:Total 424 participants aged between 30 to 75 years diagnosed with MetS according to the International Diabetes Federation criteria. Clinical exams, structured interviews, and reviews of medical records were used to gather data. Important laboratory and anthropometric data were assessed at baseline and after 6, 12, 18, and 24 months of follow-up. Regression models were used in the statistical studies, which were carried out using SPSS version 26, to evaluate the connections between the components of the MetS and the advancement of CAD.

Results:The results showed a significant positive correlation with the progression of CAD between waist circumference, systolic blood pressure, and fasting blood glucose levels (β = 0.15, p = 0.002; β = 0.18, p = 0.003; and β = 0.22, p = 0.001, respectively). Participants showed significant improvements in metabolic parameters during the 24-month follow-up period, including a drop in fasting blood glucose levels to 99.89 mg/dL and a reduction in waist circumference to 87.03 cm and systolic blood pressure to 123.87 mmHg. Furthermore, good improvements were seen in lipid profiles, demonstrating the beneficial effects of focused therapies on cardiovascular health.

Conclusion:This study indicates how crucial MetS is in accelerating CAD development. It also emphasizes how crucial early preventive and sensible risk control are for reducing cardiovascular risk.

Key Words:Metabolic syndrome, coronary artery disease, multicenter study, cardiovascular risk, cohort study.

Citation of article:Hussain G, Farooq M, Sadiq U, Ali G, Khan MSN, Tahir M,Impact of Metabolic Syndrome on the Progression of Coronary Artery Disease: An Observational Cohort Study.Med Forum2024;35(12):206-210.doi:10.60110/medforum.351246.